In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.